首页> 外文期刊>EFSA Journal >Assessment of genetically modified maize NK603 x MON810 for renewal of authorisation under Regulation (EC) No?1829/2003 (application EFSA‐GMO‐RX‐007)
【24h】

Assessment of genetically modified maize NK603 x MON810 for renewal of authorisation under Regulation (EC) No?1829/2003 (application EFSA‐GMO‐RX‐007)

机译:评估转基因玉米NK603 X MON810,用于根据监管(EC)授权更新(EC)NO?1829/2003(申请EFSA-GMO-RX-007)

获取原文
           

摘要

Following the submission of application EFSA‐GMO‐RX‐007 under Regulation (EC) No 1829/2003 from Monsanto, the Panel on Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the herbicide‐tolerant and insect‐resistant genetically modified maize NK603 x MON810. The data received in the context of this renewal application contained post‐market environmental monitoring reports, a systematic search and evaluation of literature, updated bioinformatic analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panel assessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the events in maize NK603 x MON810 considered for renewal is identical to the sequence of the originally assessed events, the GMO Panel concludes that there is no evidence in the renewal application EFSA‐GMO‐RX‐007 for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on maize NK603 x MON810.
机译:在提交申请申请下的申请(EC)中(EC)1829/2003的孟加非,欧洲食品安全管理局(GMO小组)的基因改性生物小组被要求提供科学风险评估在授权授权应用的上下文中提交的数据,耐抗虫和抗虫遗传修饰的玉米NK603 X MON810。在此续约申请的上下文中收到的数据包含市场后环境监测报告,系统的搜索和评估,更新的生物信息分析以及由申请人或代表申请人执行的额外文件或研究。 GMO小组评估了这些数据,以获得可能的新危害,修改的暴露或在授权期间确定的新科学不确定性,并在原始申请的范围内进行评估。在假设玉米NK603 X MON810中的事件的DNA序列与最初评估事件的序列相同的情况下,GMO小组得出结论,续签申请EFSA-GMO-RX-007中没有证据表明新的危险,修改的暴露或科学的不确定性,将改变原始风险评估的结论,玉米NK603 X MON810。

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号